Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AtriCure (ATRC) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $47.9 million.

  • AtriCure's Shares Outstanding (Weighted Average) rose 173.02% to $47.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.9 million, marking a year-over-year increase of 173.02%. This contributed to the annual value of $47.0 million for FY2024, which is 141.66% up from last year.
  • According to the latest figures from Q3 2025, AtriCure's Shares Outstanding (Weighted Average) is $47.9 million, which was up 173.02% from $47.7 million recorded in Q2 2025.
  • AtriCure's Shares Outstanding (Weighted Average)'s 5-year high stood at $47.9 million during Q3 2025, with a 5-year trough of $44.6 million in Q1 2021.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $46.2 million, with a median of $46.3 million in 2023.
  • Per our database at Business Quant, AtriCure's Shares Outstanding (Weighted Average) surged by 1541.47% in 2021 and then surged by 124.4% in 2023.
  • AtriCure's Shares Outstanding (Weighted Average) (Quarter) stood at $45.1 million in 2021, then grew by 1.5% to $45.7 million in 2022, then grew by 1.24% to $46.3 million in 2023, then increased by 1.42% to $47.0 million in 2024, then increased by 2.03% to $47.9 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $47.9 million for Q3 2025, versus $47.7 million for Q2 2025 and $47.4 million for Q1 2025.